Pro 2013-021 (Jianfeng Group Corporate Bond Listing Announcement)-1
Release time:
2020-08-05
Stock Abbreviations: Jianfeng Group Stock Code: 600 668 Announcement No.: Pro 2013- 021
Bond Abbreviations: 13 Peak 01 Bond Code: 122227

Zhejiang Jianfeng Group Co., Ltd.
201 3 Corporate Bonds (Phase I)
Listing Announcement
Securities Abbreviation: 13 Peak 01
Securities Code: 122227
Total Issue: RMB 3 billion Yuan
Listing Time: 2013 7 2
Listing place: shanghai Stock Exchange
Sponsor (Lead Underwriter) / Listing Recommender
( Registered Address: hangzhou Hangzhou Hangzhou Hangzhou Road 1 )
2013 7 January
Section I Introduction
Important Tips
Zhejiang Jianfeng Group Co., Ltd. (the following is called "Jianfeng Group ", "Company" or "Issuer") Members of the Board of Directors have approved this Listing Announcement, guarantee that there are no false records, misleading Chen or material omissions, and assume individual and joint legal responsibility for its truthfulness, accuracy and completeness.
The approval of the Shanghai Stock Exchange (hereinafter referred to as the "SSE" ) for the listing of corporate bonds does not indicate a substantive judgment or guarantee of the investment value of the bonds or the return of investors. Investors who purchase bonds are responsible for the investment risks arising from changes in the company's operations and earnings. 117.
has been comprehensively evaluated byof United Credit Rating Co., Ltd. (hereinafter referred to as "United Rating " ). Jianfeng Group current corporate bonds Credit rating is AA + , and the main credit rating is AA ; Before the listing of bonds, the net assets of the issuer at the end of the latest period were ,164,643.81 .38 million yuan (total owner's equity of in the consolidated statement as of 2012 , 142# December , March 31 ) , and the asset-liability ratio of consolidated statement caliber was 40.74 (the asset-liability ratio of parent company caliber was 25.77 ); before the listing of the current bonds, the average annual distributable profit realized by the issuer in the last three fiscal years was 18,836.85 .56 million yuan (average of the net profit attributable to the owners of the parent company in the consolidated statements of 20 10 , 2011 and 201 2 #), expected not less than 1.5 times the one-year interest on this issue bonds. Section II Issuer Profile
1. Issuer Legal Name
Chinese Name: Zhejiang Jianfeng Group Co., Ltd.
English Name: ZHEJIANG JIANFENG GROUP CO.,LTD
2. Issuer Registered Address and Office Address
Registered Address: No. 88 193, Wujiang East Road, Jinhua City, Zhejiang Province
Office Address: No. 88 199, Wujiang East Road, Jinhua City, Zhejiang Province
3. Issuer Registered CapitalRegistered Capital: RMB 344,083,828.00 RMB
4. Issuer Legal Representative
Legal Representative: Jiang Xiaomeng
5. Issuer Basic Information
(I) Issuer Business Scope
Issuer's business scope is:cement, cement concrete, prefabricated components, common machinery, auxiliary materials, communication equipment, caulking materials, instruments and meters, paper bags manufacturing and sales, import and export business (see approval of the Foreign Trade Office for details), and industrial investment.
Main Business of (II) Issuers
According to "Guidelines for Industry Classification of Listed Companies (2012
Revision)" (CSRC Announcement [2012 ]
31), issuers belong to "Non-metallic Mineral Products Industry" and "Pharmaceutical Manufacturing Industry". The issuer's main business is cement manufacturing and sales, pharmaceutical manufacturing and sales, pharmaceutical commercial circulation. cement business is carried out in daye peak and Yunnan peak system, the issuer's holding subsidiaries. the issuer has been engaged in this business since was listed in 1993 , accounting for about 40% of the issuer's main business income. this business is mainly engaged in the production and sales of cement and cement clinker.
pharmaceutical business is carried out within the peak pharmaceutical system of the issuer's holding subsidiary, accounting for about 50% of the issuer's main business income . The business mainly covers two categories: pharmaceutical industry and pharmaceutical commerce. Company
2010, 2011 and 2012
, with operating income of132, .09 .63 million yuan, 164, .88 .65 million yuan and 164,909.55 .67 million yuan respectively, operating income stable growth ; the proportion of main business income to operating income is above 99% . The composition of the company's main business income in the past three years is as follows: units: ten thousand yuan
industry name
2012 degree |
2011 year |
2010 year |
amount |
|||
Proportion |
Amount |
Proportion |
Amount |
Proportion |
Cement Industry |
|
63,012.93 |
38.38% |
72,736.61 |
44.45% |
51,038.47 |
38.83% |
Pharmaceutical Industry |
82,785.43 |
50.42% |
76,543.88 |
46.77% |
65,262.72 |
49.66% |
other industries |
18,379.87 |
11.20% |
14,366.78 |
8.78% |
|||
More information
Teachers and Students of Zhejiang Gongshang University Visit Peak Health
News from our newspaper On the morning of June 9, a group of 18 teachers and students from Zhejiang Gongshang University came to Jianfeng Health for a visit and discussion, and conducted research on the establishment of Zhejiang Gongshang University Food Industrialization Research Institute in Jinhua. The leader of this visit is Professor Song Guanglei from the School of Food and Biological Engineering, Zhejiang Gongshang University. The teachers and students are mainly from the School of Food and Engineering, specializing in food science, food safety, biochemical and biotechnology, focusing on extraction and separation, functional activity and The research of functional food, in addition to the professor of the Department of E-commerce of the School of Management Engineering and E-commerce. Chen Daiyou, general manager of Jianfeng Health, Li Wende, deputy general manager, and relevant personnel from R & D, quality management, administrative personnel and other departments attended the forum. Li Wende introduced the basic situation, technical production level, scientific and technological research and development characteristics of Jianfeng Health Company in the form of PPT, as well as the relevant policies of Jinhua Municipal Government on talent introduction. Chen Daiyou focused on the development vision of Jianfeng Health Technology and the construction of scientific and technological talents, and welcomed graduate students from the Industrial and Commercial University to join the team of Jianfeng Health after graduation. Professor Song Guanglei fully affirmed the software and hardware facilities and humanistic management of Jianfeng Health Company. He said that most of the teachers and students who came to visit this time were professional in line with the industry of Jianfeng Health Company. The two sides could carry out in-depth cooperation in product development, technology upgrading and talent reserve. Fourteen graduate students also introduced their respective situations and study and research directions. After the symposium, the teachers and students visited the health company's testing center, R & D laboratory and plant extraction workshop with great interest.
2020
07-31
Trial operation of large pharmacy micro-mall
The construction of the micro-mall of Jianfeng Pharmacy is basically ready at present. On June 17, Shuangxi and Donglai chain stores took the lead in the trial operation of the micro-mall. At present, online consumption through computers and mobile phones has become a way of life in China. In particular, various software represented by WeChat covers more than 90% of smart phones, and has many functions such as information exchange and online payment. It is a new type of shopping system based on WeChat platform, using mobile Internet technology to realize the integration of online and offline marketing. At present, there are more than 1000 kinds of commodities on the shelves of the micro-mall of Jianfeng pharmacy, mainly OTC commodities of over-the-counter drugs, which are basically synchronized with pharmacies. Customers only need to pay attention to the public number of Jianfeng Pharmacy and enter the micro-mall to collect coupons through the "online drug purchase" on the public number page. They can find the required drugs on the mobile phone to purchase and pay for them. The delivery method can be delivered to the door or the store can pick them up by itself. The purchase of drugs through the micro-mall is not only convenient and fast, but also can reduce the phenomenon of queuing in the store. According to reports, the opening of the micro mall by the big pharmacy is to expand the new service model and provide more and better extended services to the masses. Prior to this, the WeChat public number of the large pharmacy has already made a useful attempt to push health information, and the operation of the micro-mall will further provide users with new channels for seeking medical advice. While further improving the micro-mall system, the large pharmacy will add "online pharmacists" and other service items to provide users with real-time consulting services such as medication guidance, drug purchase recommendation, health care knowledge and so on in the form of voice or text. (Tang Wenshu)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-30
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
On May 27, the Party Committee of the Group Company held a branch secretary meeting to comprehensively review and summarize the Party building work of the Company in 2016 and sign the responsibility book for the management of Party building work objectives in 2017. At the meeting, Qin xuping, member of the party Committee of the group company and director of the party-mass work department, made a comprehensive summary of the company's party building work in 2016, put forward the 2017 work plan, and conveyed the "key points of party building work in the city's two new organizations in 2017" issued by the two new working committees of Jinhua municipal party Committee, and the spirit of the speech made by the relevant leaders of the municipal party Committee at the recent meeting of the city's two new working committee, this paper explains the "ten questions" of the two new grass-roots party organizations, the "ten questions" of Party members and some problems that need attention in the process of Party member development. Members of the party committee of the group company, secretaries of grass-roots party committees and branch secretaries expressed their views and conducted extensive exchanges on such topics as how to deepen the "two learning and one doing", further play the role of party organizations in the process of enterprise operation and management, and how to do a good job in organizational construction in 2017. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, on behalf of the party committee of the group, signed the 2017 party building work target management responsibility letter with the heads of the party organizations of various professional companies and directly affiliated enterprises. In his speech at the meeting, Jiang Xiaomeng said that the Politburo meeting of the CPC Central Committee held on the 26th reviewed and approved the "Decision on Amending the Regulations on the Inspection Work of the Communist Party of China" and other reports, which is a major measure to further implement the provisions of the party constitution and strengthen internal party supervision. Specific to the internal party building work of the enterprise, all cadres and party members should earnestly study relevant policies and documents, and earnestly understand the spirit of the central government
2020
07-31